The Monoclonal Gammopathies of Renal Significance

1. Long, T.E., Indridason, O.S., Palsson, R. et al. Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study. Blood Cancer J. 12, 133 (2022). https://doi.org/10.1038/s41408-022-00732-3 LongT.E. IndridasonO.S. PalssonR. Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study Blood Cancer J 12 133 2022 https://doi.org/10.1038/s41408-022-00732-3 Search in Google Scholar

2. Ďurovcová E. Monoklonové gamapatie – laboratórne vyšetrenia v diagnostike a monitorovaní. Newslab, 2016; roč. 7(1): 25–29 ĎurovcováE. Monoklonové gamapatie – laboratórne vyšetrenia v diagnostike a monitorovaní Newslab 2016 roč. 7 1 25 29 Search in Google Scholar

3. Chen LY, Drayson M, Bunce C, et al. Monoclonal gammopathy of increasing significance: time to screen? Haematologica. 2023 Jun 1;108(6):1476–1486. doi: 10.3324/haematol.2022.281802. PMID: 36373250; PMCID: PMC10233333. ChenLY DraysonM BunceC Monoclonal gammopathy of increasing significance: time to screen? Haematologica 2023 Jun 1 108 6 1476 1486 10.3324/haematol.2022.281802 36373250 PMC10233333 Open DOISearch in Google Scholar

4. Leung N, Bridoux F, Batuman V, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol. 2019 Jan;15(1):45–59. doi: 10.1038/s41581-018-0077-4. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121. PMID: 30510265; PMCID: PMC7136169. LeungN BridouxF BatumanV The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group Nat Rev Nephrol 2019 Jan 15 1 45 59 10.1038/s41581-018-0077-4 Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121. 30510265 PMC7136169 Open DOISearch in Google Scholar

5. Hutchison CA, Batuman V, Behrens J, et al. International Kidney and Monoclonal Gammopathy Research Group. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol. 2011 Nov 1;8(1):43–51. doi: 10.1038/nrneph.2011.168. PMID: 22045243; PMCID: PMC3375610. HutchisonCA BatumanV BehrensJ International Kidney and Monoclonal Gammopathy Research Group The pathogenesis and diagnosis of acute kidney injury in multiple myeloma Nat Rev Nephrol 2011 Nov 1 8 1 43 51 10.1038/nrneph.2011.168 22045243 PMC3375610 Open DOISearch in Google Scholar

6. Leung N, Bridoux F, Hutchison CA, et al. International Kidney and Monoclonal Gammopathy Research Group. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood. 2012 Nov 22;120(22):4292–5. doi: 10.1182/blood-2012-07-445304. Epub 2012 Oct 9. Review. PubMed PMID: 23047823. LeungN BridouxF HutchisonCA International Kidney and Monoclonal Gammopathy Research Group Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant Blood 2012 Nov 22 120 22 4292 5 10.1182/blood-2012-07-445304 Epub 2012 Oct 9. Review. 23047823 Open DOISearch in Google Scholar

7. Yadav P, Sathick IJ, Leung N, et al. Serum free light chain level at diagnosis in myeloma cast nephropathy-a multicentre study. Blood Cancer J. 2020 Mar 3;10(3):28. doi: 10.1038/s41408-020-0295-4. PMID: 32127527; PMCID: PMC7054310. YadavP SathickIJ LeungN Serum free light chain level at diagnosis in myeloma cast nephropathy-a multicentre study Blood Cancer J 2020 Mar 3 10 3 28 10.1038/s41408-020-0295-4 32127527 PMC7054310 Open DOISearch in Google Scholar

8. Alonso-Titos J, Martínez-Esteban M, López V, et al. Monoclonal gammopathy of renal significance: Early diagnosis is key. Nefrología. Vol. 41. Issue. 5. September – October 2021 pages 489–604. DOI: 10.1016/j.nefroe.2021.11.008 Alonso-TitosJ Martínez-EstebanM LópezV Monoclonal gammopathy of renal significance: Early diagnosis is key Nefrología 41 5 September – October 2021 489 604 10.1016/j.nefroe.2021.11.008 Open DOISearch in Google Scholar

9. Kariyawasan C. C, Hughes D.A, Jayatillake M.M, et al. Multiple myeloma: causes and consequences of delay in diagnosis, QJM: An International Journal of Medicine, Volume 100, Issue 10, October 2007, Pages 635–640, https://doi.org/10.1093/qjmed/hcm077 KariyawasanC. C HughesD.A JayatillakeM.M Multiple myeloma: causes and consequences of delay in diagnosis QJM: An International Journal of Medicine 100 10 October 2007 635 640 https://doi.org/10.1093/qjmed/hcm077 Search in Google Scholar

10. Dispenzieri A, Kyle RA, Merlini G, et al. International myeloma working group guidelines for serum free light chain analysis in multiple myeloma and related disorders. Leukemia. 2009;23:215–224. DispenzieriA KyleRA MerliniG International myeloma working group guidelines for serum free light chain analysis in multiple myeloma and related disorders Leukemia 2009 23 215 224 Search in Google Scholar

11. Frank B, Nelson L, Colin A H, et al. Diagnosis of monoclonal gammopathy of renal significance. Kidney International. Volume 87, Issue 4, 2015, Pages 698–711, ISSN 0085-2538, https://doi.org/10.1038/ki.2014.408. FrankB NelsonL ColinA H Diagnosis of monoclonal gammopathy of renal significance Kidney International 87 4 2015 698 711 ISSN 0085-2538, https://doi.org/10.1038/ki.2014.408. Search in Google Scholar

12. Schmidt A. Multiple Myeloma with a Special Focus on Precision Medicine. Healthbook TIMES Oncology Hematology. Vol. 6, Issue 4, 2020. December 07, 2020 CEST. Vol. 6, Issue 4, 2020 December 07 SchmidtA. Multiple Myeloma with a Special Focus on Precision Medicine Healthbook TIMES Oncology Hematology 6 4 2020 December 07 2020 CEST 6 4 2020 December 07 Search in Google Scholar

13. Yadav P, Leung N, Sanders PW, et al. The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease. Kidney Int. 2015 Apr;87(4):692–7. doi: 10.1038/ki.2014.333. Epub 2014 Oct 8. PMID: 25296094; PMCID: PMC4863638. YadavP LeungN SandersPW The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease Kidney Int 2015 Apr 87 4 692 7 10.1038/ki.2014.333 Epub 2014 Oct 8. 25296094 PMC4863638 Open DOISearch in Google Scholar

14. Adam Z, Pour L, Harvanová Ľ. Monoklonálne gamapatie klinického významu a další nemoci Grada Publishing, Prague, 2023, p.118–119. AdamZ PourL HarvanovἠMonoklonálne gamapatie klinického významu a další nemoci Grada Publishing Prague 2023 118 119 Search in Google Scholar

15. Castillo JJ, Callander NS, Baljevic M, et al. The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance. Am J Hematol. 2021 Jul 1;96(7):846–853. doi: 10.1002/ajh.26155. Epub 2021 Mar 25. PMID: 33709474; PMCID: PMC8252623. CastilloJJ CallanderNS BaljevicM The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance Am J Hematol 2021 Jul 1 96 7 846 853 10.1002/ajh.26155 Epub 2021 Mar 25. 33709474 PMC8252623 Open DOISearch in Google Scholar

16. Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020 May;95(5):548–567. doi: 10.1002/ajh.25791. Erratum in: Am J Hematol. 2020 Nov;95(11):1444. doi: 10.1002/ajh.25876. PMID: 32212178. RajkumarSV Multiple myeloma: 2020 update on diagnosis, risk-stratification and management Am J Hematol 2020 May 95 5 548 567 10.1002/ajh.25791 Erratum in: Am J Hematol. 2020 Nov;95(11):1444. 10.1002/ajh.25876 32212178 Open DOISearch in Google Scholar

17. Motáň V, Vachek J. Diagnostika mnohočetného myelomu: minimum pro nehematology. Acta medicinae. 17/2021 MotáňV VachekJ Diagnostika mnohočetného myelomu: minimum pro nehematology Acta medicinae 17 2021 Search in Google Scholar